282 related articles for article (PubMed ID: 20971593)
21. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
22. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
Palmieri GF; Wehrlé P; Martelli S
Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
[TBL] [Abstract][Full Text] [Related]
23. Improvement of solubility and oral bioavailability of 2-(N-cyanoimino)-5-[(E)-4-styrylbenzylidene]-4-oxothiazolidine (FPFS-410) with antidiabetic and lipid-lowering activities in dogs by 2-hydroxypropyl-beta-cyclodextrin.
Hara T; Hirayama F; Arima H; Yamaguchi Y; Uekama K
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):344-9. PubMed ID: 16508189
[TBL] [Abstract][Full Text] [Related]
24. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
25. Investigation of the inclusion of the herbicide metobromuron in native cyclodextrins by powder X-ray diffraction and isothermal titration calorimetry.
Smith VJ; Rougier NM; de Rossi RH; Caira MR; Buján EI; Fernández MA; Bourne SA
Carbohydr Res; 2009 Nov; 344(17):2388-93. PubMed ID: 19800052
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
27. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
Miyake K; Hirayama F; Uekama K
J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
[TBL] [Abstract][Full Text] [Related]
28. Thermodynamics of propylparaben/beta-cyclodextrin inclusion complexes.
Zughul MB; al-Omari M; Badwan AA
Pharm Dev Technol; 1998 Feb; 3(1):43-53. PubMed ID: 9532599
[TBL] [Abstract][Full Text] [Related]
29. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
Ventura CA; Tommasini S; Falcone A; Giannone I; Paolino D; Sdrafkakis V; Mondello MR; Puglisi G
Int J Pharm; 2006 May; 314(1):37-45. PubMed ID: 16581211
[TBL] [Abstract][Full Text] [Related]
30. Physicochemical properties of inclusion complexes of highly soluble β-cyclodextrins with highly hydrophobic testosterone propionate.
Celia C; Scala A; Stancanelli R; Surdo E; Paolino D; Grattoni A; Micale N; Crupi V; Majolino D; Fresta M; Tommasini S; Venuti V; Ventura CA
Int J Pharm; 2017 Dec; 534(1-2):316-324. PubMed ID: 29042336
[TBL] [Abstract][Full Text] [Related]
31. Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins.
Mady FM; Farghaly Aly U
Drug Des Devel Ther; 2017; 11():1681-1692. PubMed ID: 28652706
[TBL] [Abstract][Full Text] [Related]
32. Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin.
Pápay ZE; Sebestyén Z; Ludányi K; Kállai N; Balogh E; Kósa A; Somavarapu S; Böddi B; Antal I
J Pharm Biomed Anal; 2016 Jan; 117():210-6. PubMed ID: 26363816
[TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
34. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
[TBL] [Abstract][Full Text] [Related]
35. Comparative study on inclusion complexation of maltosyl-beta-cyclodextrin, heptakis(2,6-di-O-methyl)-beta-cyclodextrin and beta-cyclodextrin with fucosterol in aqueous and solid state.
Acartürk F; Imai T; Saito H; Ishikawa M; Otagiri M
J Pharm Pharmacol; 1993 Dec; 45(12):1028-32. PubMed ID: 7908969
[TBL] [Abstract][Full Text] [Related]
36. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
Garnero C; Longhi M
J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
[TBL] [Abstract][Full Text] [Related]
37. Study of the physicochemical properties of trimethoprim with beta-cyclodextrin in solution.
Li N; Zhang YH; Xiong XL; Li ZG; Jin XH; Wu YN
J Pharm Biomed Anal; 2005 Jun; 38(2):370-4. PubMed ID: 15925234
[TBL] [Abstract][Full Text] [Related]
38. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
39. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
40. [Preparation of coated tablets of glycyrrhetic acid-HP-beta-cyclodextrin tablets for colon-specific release].
Cui QH; Cui JH; Zhang JJ
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2339-43. PubMed ID: 19157122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
